Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
RLMD
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
RLMD: Relmada Therapeutics, Inc. Stock Analysis | finqOS
RLMD
$2.62
−15.76%
Lists
Call RLMD
Relmada Therapeutics
RLMD
Back
Lists
Call RLMD
$2.62
−$0.49 · −15.76%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
43%
in three months and at its 52-week low.
Call RLMD
Loading chart data...
Signal state